Pink Sheet Podcast: SubQ Drugs And Price Negotiations, GLP-1s In Court, US FDA Approach To Black Box AI

 
• By Derrick Gingery, Sarah Karlin-Smith, Cathy Kelly, and Nielsen Hobbs

Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations, legal wrangling related to compounding GLP-1 drugs for obesity and diabetes, and the varying opinions of FDA officials on the acceptability of artificial intelligence models that are not fully explainable.

Pink Sheet podcast
Will the FDA successfully defend its GLP-1 shortage decision? • Source: Citeline/Shutterstock

More from Podcasts

More from Compliance